TLIS Key Statistics, Chart & Performance
The current stock price of TLIS is 4.38 USD. In the past month the price decreased by -50.79%. In the past year, price decreased by -27.24%.
TLIS Latest News, Press Relases and Analysis
TLIS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.19 | 218.55B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.79 | 200.79B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.4 | 146.06B | ||
| SYK | STRYKER CORP | 27.86 | 140.33B | ||
| IDXX | IDEXX LABORATORIES INC | 57.72 | 58.12B | ||
| BDX | BECTON DICKINSON AND CO | 13.32 | 55.07B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.99 | 49.20B | ||
| RMD | RESMED INC | 25.48 | 36.82B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.87 | 37.37B | ||
| DXCM | DEXCOM INC | 34.87 | 25.29B | ||
| PODD | INSULET CORP | 67.18 | 21.60B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.63 | 18.64B |
Related stock screener links
About TLIS
Company Profile
Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company is headquartered in Chicago, Illinois and currently employs 99 full-time employees. The company went IPO on 2021-02-12. The firm is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.
Company Info
TALIS BIOMEDICAL CORP
1375 West Fulton Market, Suite 700
Chicago ILLINOIS 94025 US
CEO: Brian Coe
Employees: 99
Phone: 16504333000
TALIS BIOMEDICAL CORP / TLIS FAQ
Can you describe the business of TALIS BIOMEDICAL CORP?
Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company is headquartered in Chicago, Illinois and currently employs 99 full-time employees. The company went IPO on 2021-02-12. The firm is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.
What is the current price of TLIS stock?
The current stock price of TLIS is 4.38 USD. The price increased by 5.29% in the last trading session.
Does TLIS stock pay dividends?
TLIS does not pay a dividend.
What is the ChartMill technical and fundamental rating of TLIS stock?
TLIS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for TALIS BIOMEDICAL CORP?
TALIS BIOMEDICAL CORP (TLIS) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Is TALIS BIOMEDICAL CORP (TLIS) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TLIS.
How many employees does TALIS BIOMEDICAL CORP have?
TALIS BIOMEDICAL CORP (TLIS) currently has 99 employees.
TLIS Technical Analysis
TLIS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TLIS. TLIS has a great financial health rating, but its profitability evaluates not so good.
TLIS Financial Highlights
Over the last trailing twelve months TLIS reported a non-GAAP Earnings per Share(EPS) of -31.43. The EPS increased by 42.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -69.35% | ||
| ROE | -100.93% | ||
| Debt/Equity | 0 |
TLIS Forecast & Estimates
6 analysts have analysed TLIS and the average price target is 5.1 USD. This implies a price increase of 16.44% is expected in the next year compared to the current price of 4.38.
For the next year, analysts expect an EPS growth of 27.62% and a revenue growth -100% for TLIS